
Tiffany Maureen Gough
Examiner (ID: 1, Phone: (571)272-0697 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1657, 1651 |
| Total Applications | 686 |
| Issued Applications | 179 |
| Pending Applications | 92 |
| Abandoned Applications | 428 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18629553
[patent_doc_number] => 20230288437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => QUANTIFICATION METHOD FOR MODIFIED HDL, AND ANALYSIS REAGENT FOR USE IN SAME METHOD
[patent_app_type] => utility
[patent_app_number] => 17/907746
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907746
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907746 | QUANTIFICATION METHOD FOR MODIFIED HDL, AND ANALYSIS REAGENT FOR USE IN SAME METHOD | Mar 28, 2021 | Pending |
Array
(
[id] => 17112144
[patent_doc_number] => 20210292741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS)
[patent_app_type] => utility
[patent_app_number] => 17/208107
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208107 | COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS) | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17299874
[patent_doc_number] => 20210395713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => DEIMMUNIZED LYSOSTAPHIN AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/199484
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199484 | Deimmunized lysostaphin and methods of use | Mar 11, 2021 | Issued |
Array
(
[id] => 19536940
[patent_doc_number] => 12129481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Use of cells derived from first trimester umbilical cord tissue
[patent_app_type] => utility
[patent_app_number] => 17/181482
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 40
[patent_no_of_words] => 32478
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181482 | Use of cells derived from first trimester umbilical cord tissue | Feb 21, 2021 | Issued |
Array
(
[id] => 16899720
[patent_doc_number] => 20210178636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => Method for Engineering Three-Dimensional Synthetic Vascular Networks Through Mechanical Micromachining and Mutable Polymer Micromolding
[patent_app_type] => utility
[patent_app_number] => 17/170706
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170706
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170706 | Method for Engineering Three-Dimensional Synthetic Vascular Networks Through Mechanical Micromachining and Mutable Polymer Micromolding | Feb 7, 2021 | Abandoned |
Array
(
[id] => 16993270
[patent_doc_number] => 20210231690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => IN VITRO METHOD, USE OF AN AGENT AND COLLECTION DEVICE FOR THE INHIBITION OF COAGULATION IN BLOOD
[patent_app_type] => utility
[patent_app_number] => 17/164080
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/164080 | IN VITRO METHOD, USE OF AN AGENT AND COLLECTION DEVICE FOR THE INHIBITION OF COAGULATION IN BLOOD | Jan 31, 2021 | Abandoned |
Array
(
[id] => 18210099
[patent_doc_number] => 20230056360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => BLOOD-BRAIN-BARRIER SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/796018
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10381
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796018 | BLOOD-BRAIN-BARRIER SYSTEMS | Jan 27, 2021 | Pending |
Array
(
[id] => 18193688
[patent_doc_number] => 20230047207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Self-Contained Biological Indicator with Salt Compound
[patent_app_type] => utility
[patent_app_number] => 17/758585
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758585
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758585 | Self-Contained Biological Indicator with Salt Compound | Jan 13, 2021 | Pending |
Array
(
[id] => 18210586
[patent_doc_number] => 20230056848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TURKEY COLLAGEN HYDROLYSATES AND METHODS OF MAKING
[patent_app_type] => utility
[patent_app_number] => 17/758694
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12357
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/758694 | Turkey collagen hydrolysates and methods of making | Jan 12, 2021 | Issued |
Array
(
[id] => 18198779
[patent_doc_number] => 20230052298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => LACTIC ACID BACTERIUM FERMENTATION PROMOTER
[patent_app_type] => utility
[patent_app_number] => 17/789045
[patent_app_country] => US
[patent_app_date] => 2020-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789045 | LACTIC ACID BACTERIUM FERMENTATION PROMOTER | Dec 23, 2020 | Pending |
Array
(
[id] => 18005370
[patent_doc_number] => 20220364136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Improved Methods for Purification of Sophorolipids
[patent_app_type] => utility
[patent_app_number] => 17/765552
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765552 | Methods for purification of sophorolipids | Dec 17, 2020 | Issued |
Array
(
[id] => 18166999
[patent_doc_number] => 20230033606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => MULTI-STRAIN PROBIOTIC COMPOSITION AND ITS USE
[patent_app_type] => utility
[patent_app_number] => 17/784154
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784154 | MULTI-STRAIN PROBIOTIC COMPOSITION AND ITS USE | Dec 16, 2020 | Abandoned |
Array
(
[id] => 16945892
[patent_doc_number] => 20210204583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => COMPOSITION FOR PREVENTING, RELIEVING OR TREATING CLIMACTERIC DISORDERS COMPRISING LACTIC ACID BACTERIA AND PREBIOTICS
[patent_app_type] => utility
[patent_app_number] => 16/952635
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952635
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952635 | Composition for preventing, relieving or treating climacteric disorders comprising lactic acid bacteria and prebiotics | Nov 18, 2020 | Issued |
Array
(
[id] => 18108049
[patent_doc_number] => 20230000929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => BDELLOVIBRIO TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 17/780436
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780436
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780436 | BDELLOVIBRIO TREATMENT FOR AMYOTROPHIC LATERAL SCLEROSIS | Nov 18, 2020 | Abandoned |
Array
(
[id] => 16673468
[patent_doc_number] => 20210062231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => METHOD AND AN APPARATUS FOR TREATING PLANT BASED RAW MATERIAL WITH AN ENZYMATIC HYDROLYSIS
[patent_app_type] => utility
[patent_app_number] => 17/081844
[patent_app_country] => US
[patent_app_date] => 2020-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17081844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/081844 | Method and an apparatus for treating plant based raw material with an enzymatic hydrolysis | Oct 26, 2020 | Issued |
Array
(
[id] => 19613195
[patent_doc_number] => 20240398875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => PROBIOTIC COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/769301
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769301 | PROBIOTIC COMPOSITIONS AND METHODS | Oct 15, 2020 | Abandoned |
Array
(
[id] => 18003527
[patent_doc_number] => 20220362293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Treatment of Mitochondrial Deficits and Age-Related Diseases Using Blood Products
[patent_app_type] => utility
[patent_app_number] => 17/763005
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763005
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763005 | Treatment of Mitochondrial Deficits and Age-Related Diseases Using Blood Products | Sep 23, 2020 | Abandoned |
Array
(
[id] => 17983868
[patent_doc_number] => 20220349904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Cardiovascular Risk Event Prediction and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/637128
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637128 | Cardiovascular Risk Event Prediction and Uses Thereof | Sep 1, 2020 | Pending |
Array
(
[id] => 16485353
[patent_doc_number] => 20200378956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => HUMAN MICROPHYSIOLOGICAL CELL SYSTEM FOR LIVER DISEASE CONVERSTION PROV 1-18585 AND PROV 2-19154
[patent_app_type] => utility
[patent_app_number] => 16/995405
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16995405
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/995405 | HUMAN MICROPHYSIOLOGICAL CELL SYSTEM FOR LIVER DISEASE CONVERSTION PROV 1-18585 AND PROV 2-19154 | Aug 16, 2020 | Pending |
Array
(
[id] => 18247611
[patent_doc_number] => 11604190
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-14
[patent_title] => Chromogenic medium for the detection and identification of vancomycin resistant enterococci and method therefor
[patent_app_type] => utility
[patent_app_number] => 16/991502
[patent_app_country] => US
[patent_app_date] => 2020-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 7083
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 333
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16991502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/991502 | Chromogenic medium for the detection and identification of vancomycin resistant enterococci and method therefor | Aug 11, 2020 | Issued |